Iranian Journal of Pathology

Trichosporon Urinary Tract Infections: A Hidden Menace Revealed

Document Type : Review Article

Authors

Ahmad Elmimoghaddam 1
Mahmoud Vahidi 1, 2
Reza Heidari 1, 3
Mahdi Ghorbani 2
Peyman Aslani 4

1 Medical Biotechnology Research Center, AJA University of Medical Sciences, Tehran, Iran

2 Department of Medical Laboratory Sciences, School of Allied Medical Sciences, AJA University of Medical Sciences, Tehran, Iran

3 Research Center for Cancer Screening and Epidemiology, AJA University of Medical Sciences, Tehran, Iran

4 Department of Parasitology & Mycology, Faculty of Medicine, AJA University of Medical Sciences, Tehran, Iran

https://doi.org/10.30699/ijp.2025.2039595.3348
Abstract
Urinary tract infections (UTIs) caused by Trichosporon are a significant concern for hospitalized patients and those with weakened immune systems. This narrative review study aims to provide a comprehensive overview of UTIs caused by Trichosporon, including its frequency, risk factors, laboratory diagnostic aspects, drug resistance, and the importance of accurate identification in clinical settings. A search of international databases was conducted to identify relevant studies, and it was found that Trichosporon asahii, specifically the G1 type, is the predominant causative agent of UTIs among various Trichosporon species. Prolonged hospitalization and immunosuppressive drug use were identified as significant risk factors for this fungal infection. Conventional methods for laboratory identification are commonly used. Still, rapid and accurate tools such as Matrix-Assisted Laser Desorption-Ionisation-Time of Flight Mass Spectrometry (MALDI-TOF MS) and DNA sequencing can improve the diagnostic process. Against all T. asahii isolates for which this triazole, polyene, and echinocandin were tested, voriconazole demonstrated the most potent in vitro activity, while amphotericin B had high MIC values and echinocandins had inherent resistance. This review provides valuable insights into the clinical significance and management of UTIs caused by Trichosporon.

Keywords

Microbial sensitivity test
Cutaneotrichosporon
Trichosporon
Urinary Tract Infections

Subjects

  1. Tan CW, Chlebicki MP. Urinary tract infections in adults. Singapore Med J. 2016;57(9):485-90. [DOI:10.11622/smedj.2016153] [PMID] [PMCID]
  2. Nitzan O, Elias M, Chazan B, Saliba W. Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management. Diabetes Metab Syndr Obes. 2015;8:129-36. [DOI:10.2147/DMSO.S51792] [PMID] [PMCID]
  3. Tandogdu Z, Wagenlehner FM. Global epidemiology of urinary tract infections. Curr Opin Infect Dis. 2016;29(1):73-9. [DOI:10.1097/QCO.0000000000000228] [PMID]
  4. Shiralizadeh S, Taghizadeh S, Asgharzadeh M, Shokouhi B, Gholizadeh P, Rahbar M, et al. Urinary tract infections: raising problem in developing countries. Rev Res Med Microbiol. 2018;29(4):159-65. [DOI:10.1097/MRM.0000000000000144]
  5. Schmiemann G, Kniehl E, Gebhardt K, Matejczyk MM, Hummers-Pradier E. The diagnosis of urinary tract infection: a systematic review. Dtsch Arztebl Int. 2010 May;107(21):361-7. [doi: 10.3238/arztebl.2010.0361] [PMID] [PMCID]
  6. Zhu C, Wang DQ, Zi H, Huang Q, Gu JM, Li LY, et al. Epidemiological trends of urinary tract infections, urolithiasis and benign prostatic hyperplasia in 203 countries and territories from 1990 to 2019. Mil Med Res. 2021;8(1):64. [DOI:10.1186/s40779-021-00359-8] [PMID] [PMCID]
  7. Öztürk R, Murt A. Epidemiology of urological infections: a global burden. World J Urol. 2020;38(11):2669-2679. [DOI:10.1007/s00345-019-03071-4] [PMID]
  8. Sobel JD, Vazquez JA. Fungal infections of the urinary tract. World J Urol. 1999;17(6):410-4. [DOI:10.1007/s003450050167] [PMID]
  9. Mattede Md, Piras C, Mattede KD, Ferrari AT, Baldotto LS, Assbu MS. Urinary tract infections due to Trichosporon spp. in severely ill patients in an intensive care unit. Rev Bras Ter Intensiva. 2015;27(3):247-51. [DOI:10.5935/0103-507X.20150045] [PMID] [PMCID]
  10. Fagundes Júnior AA, Carvalho RT, Focaccia R, Fernandez JG, Araújo HB, Strabelli TM, et al. Emergência de infecção por Trichosporon asahii em pacientes portadores de insuficiência cardíaca em unidade de terapia intensiva cardiológica: relato de caso e revisão da literatura. Rev Bras Ter Intensiva. 2008;20(1):106-9. [DOI:10.1590/S0103-507X2008000100018] [PMID]
  11. Sellami A, Sellami H, Trabelsi H, Makni F, Néji S, Cheikhrouhou F, et al. Fongémie fatale à Trichosporon asahii: À propos des deux premiers cas à Sfax (Tunisie). J Mycol Med. 2010;20(2):133-5. [DOI:10.1016/j.mycmed.2010.04.001]
  12. Servonnet A, Bourgault M, Trueba F, Sarret D, Nicand E. Infection invasive à Trichosporon asahii. Ann Biol Clin. 2010;68(3):363-6. [DOI:10.1684/abc.2010.0444] [PMID]
  13. Lacroix C, De Feuilhade Chauvin M. Infections dues à Trichosporon spp. et à Geotrichum spp. EMC- Maladies Infectieuses. 2005;2(2):97-104. [DOI:10.1016/j.emcmi.2005.01.001]
  14. Darier J, Simon C. Nouvelle pratique dermatologique. J Am Med Assoc. 1939;112(16):1630. [DOI:10.1001/jama.1939.02800160094032]
  15. Mehta V, Nayyar C, Gulati N, Singla N, Rai S, Chandar J. A Comprehensive Review of Trichosporon spp.: An Invasive and Emerging Fungus. Cureus. 2021;13(8):e17345. [DOI:10.7759/cureus.17345]
  16. Colombo AL, Padovan AC, Chaves GM. Current knowledge of Trichosporon spp. and Trichosporonosis. Clin Microbiol Rev. 2011;24(4): 682-700. [DOI:10.1128/CMR.00003-11] [PMID] [PMCID]
  17. de Almeida Júnior JN, Hennequin C. Invasive Trichosporon Infection: a Systematic Review on a Re-emerging Fungal Pathogen. Front Microbiol. 2016; 7:1629. [DOI:10.3389/fmicb.2016.01629] [PMID] [PMCID]
  18. Liu XZ, Wang QM, Göker M, Groenewald M, Kachalkin AV, Lumbsch HT, et al. Towards an integrated phylogenetic classification of the Tremellomycetes. Stud Mycol. 2015;81(1):85-147. [DOI:10.1016/j.simyco.2015.12.001] [PMID] [PMCID]
  19. Guo LN, Yu SY, Hsueh PR, Al-Hatmi AMS, Meis JF, Hagen F, et al. Invasive Infections Due to Trichosporon: Species Distribution, Genotyping, and Antifungal Susceptibilities from a Multicenter Study in China. J Clin Microbiol. 2019;57(2):e01505-18. [DOI:10.1128/JCM.01505-18] [PMID] [PMCID]
  20. Francisco EC, de Almeida Junior JN, de Queiroz Telles F, Aquino VR, Mendes AVA, de Andrade Barberino MGM, et al. Species distribution and antifungal susceptibility of 358 Trichosporon clinical isolates collected in 24 medical centres. Clin Microbiol Infect. 2019;25(7):909.e1-909.e5. [DOI:10.1016/j.cmi.2019.03.026] [PMID]
  21. Khan ID, Sahni AK, Basu A, Haleem S. Trichosporon asahii urinary tract infection in immunocompetent patients. Med J Armed Forces India. 2015;71(4):373-6. [DOI:10.1016/j.mjafi.2014.08.013] [PMID] [PMCID]
  22. Sabharwal ER. Successful management of Trichosporon asahii urinary tract infection with fluconazole in a diabetic patient. Indian J Pathol Microbiol. 2010;53(2):387-8. [DOI:10.4103/0377-4929.64320] [PMID]
  23. Sugita T, Ichikawa T, Matsukura M, Sueda M, Takashima M, Ikeda R, et al. Genetic diversity and biochemical characteristics of Trichosporon asahii isolated from clinical specimens, houses of patients with summer-type-hypersensitivity pneumonitis, and environmental materials. J Clin Microbiol. 2001 ;39(7):2405-11. [DOI:10.1128/JCM.39.7.2405-2411.2001] [PMID] [PMCID]
  24. Kontoyiannis DP, Torres HA, Chagua M, Hachem R, Tarrand JJ, Bodey GP, et al. Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome. Scand J Infect Dis. 2004;36(8):564-9. [DOI:10.1080/00365540410017563] [PMID]
  25. Ruan SY, Chien JY, Hsueh PR. Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan. Clin Infect Dis. 2009;49(1):e11-7. [DOI:10.1086/599614] [PMID]
  26. Silva V, Zepeda G, Alvarado D. Infección urinaria nosocomial por Trichosporon asahii. Primeros dos casos en Chile. Rev Iberoam Micol. 2003;20(1):21-3.
  27. Cronyn V, Howard J, Chiang L, Le L, Tims-Cook Z, Gertz AM. Trichosporon asahii Urinary Tract Infection in a Patient with Severe COVID-19. Case Rep Infect Dis. 2021;2021(1):6841393. [DOI:10.1155/2021/6841393] [PMID] [PMCID]
  28. Li H, Guo M, Wang C, Li Y, Fernandez AM, Ferraro TN, et al. Epidemiological study of Trichosporon asahii infections over the past 23 years. Epidemiol Infect. 2020;148:e169. [PMID] [PMCID] [DOI:10.1017/S0950268820001624]
  29. Arastehfar A, de Almeida Júnior JN, Perlin DS, Ilkit M, Boekhout T, Colombo AL. Multidrug-resistant Trichosporon species: underestimated fungal pathogens posing imminent threats in clinical settings. Crit Rev Microbiol. 2021;47(6):679-98. [DOI:10.1080/1040841X.2021.1921695] [PMID]
  30. Wongsuk T, Boonsilp S, Pumeesat P, Homkaew A, Sangsri T, Chongtrakool P. Genotyping, antifungal susceptibility testing, and biofilm formation of Trichosporon spp. isolated from urine samples in a University Hospital in Bangkok, Thailand. Acta Microbiol Immunol Hung. 2022;69(3):247-257. [DOI:10.1556/030.2022.01797] [PMID]
  31. Turan D, Barış A, Özakkaş F, Dinçer ŞD, Aksaray S. Investigation of Antifungal Susceptibility of Trichosporon Asahii Isolated From Urine Samples. Med J Bakirkoy. 2021;17(2):130-4. DOI: 10.4274/BMJ.galenos.2021.54254. [DOI:10.4274/BMJ.galenos.2021.54254]
  32. Francisco EC, de Almeida Junior JN, Queiroz-Telles F, Aquino VR, Mendes AVA, de Oliveira Silva M, et al. Correlation of Trichosporon asahii Genotypes with Anatomical Sites and Antifungal Susceptibility Profiles: Data Analyses from 284 Isolates Collected in the Last 22 Years across 24 Medical Centers. Antimicrob Agents Chemother. 2021;65(3):e01104-20. [DOI:10.1128/AAC.01104-20] [PMID] [PMCID]
  33. Mehta V, Chander J, Gulati N, Singla N, Vasdeva H, Sardana R, et al. Epidemiological profile and antifungal susceptibility pattern of Trichosporon species in a tertiary care hospital in Chandigarh, India. Curr Med Mycol. 2021;7(1):19-24. [DOI:10.18502/cmm.7.1.6179] [PMID] [PMCID]
  34. Zarei F, Hashemi SJ, Salehi M, Mahmoudi S, Zibafar E, Ahmadinejad Z, et al. Molecular characterization of fungi causing colonization and infection in organ transplant recipients: A one-year prospective study. Curr Med Mycol. 2020;6(1):30-35. [DOI:10.18502/cmm.6.1.2505] [PMID] [PMCID]
  35. R E, Princess I, Vadala R, Kumar S, Ramakrishnan N, Krishnan G. Microbiological Profile of Infections in a Tertiary Care Burns Unit. Indian J Crit Care Med. 2019;23(9):405-410. [DOI:10.5005/jp-journals-10071-23234] [PMID] [PMCID]
  36. El-Mashad NB, Aal AM, Elewa AM, Elshaer MY. Nosocomial yeast infections among cancer patients in Egypt: species distribution and antifungal susceptibility profile. Jundishapur J Microbiol. 2019;12(2):82421. [DOI:10.5812/jjm.82421]
  37. Sierra-Díaz E, Hernández-Ríos CJ, Bravo-Cuellar A. Antibiotic resistance: Microbiological profile of urinary tract infections in Mexico. Cir Cir. 2019; 87(2):176-182. [DOI:10.24875/CIRU.18000494] [PMID]
  38. Taei M, Chadeganipour M, Mohammadi R. An alarming rise of non-albicans Candida species and uncommon yeasts in the clinical samples; a combination of various molecular techniques for identification of etiologic agents. BMC Res Notes. 2019;12(1):779. [DOI:10.1186/s13104-019-4811-1] [PMID] [PMCID]
  39. Montoya AM, Elizondo-Zertuche M, Treviño-Rangel RJ, Becerril-García M, González GM. Biofilm formation and antifungal susceptibility of Trichosporon asahii isolates from Mexican patients. Rev Iberoam Micol. 2018;35(1):22-26. [DOI:10.1016/j.riam.2017.02.008] [PMID]
  40. Yang YL, Chu WL, Lin CC, Zhou ZL, Chen PN, Lo HJ. Mixed yeast infections in Taiwan. Med Mycol. 2018;56(6):770-773. [DOI:10.1093/mmy/myx094] [PMID]
  41. Hazirolan G, Koçak N, Karagöz A. Sequence-based identification, genotyping and virulence factors of Trichosporon asahii strains isolated from urine samples of hospitalized patients (2011-2016). J Mycol Med. 2018;28(3):452-456. [DOI:10.1016/j.mycmed.2018.06.006] [PMID]
  42. García-Agudo L, Rodríguez-Iglesias M, Carranza-González R. Nosocomial Candiduria in the Elderly: Microbiological Diagnosis. Mycopathologia. 2018; 183(3):591-596. [DOI:10.1007/s11046-017-0232-7] [PMID]
  43. Kim SH, Song SA, Urm SH, Kook JK, Kim HR, Yong D, et al. Evaluation of the Cobas u 701 microscopy analyser compared with urine culture in screening for urinary tract infection. J Med Microbiol. 2017;66(8): 1110-1113. [DOI:10.1099/jmm.0.000553] [PMID]
  44. Lai CC, Lee CM, Chiang HT, Hung CT, Chen YC, Su LH, et al. Infection Control Society of Taiwan. Implementation of a national bundle care program to reduce catheter-associated urinary tract infection in high-risk units of hospitals in Taiwan. J Microbiol Immunol Infect. 2017;50(4):464-470. [DOI:10.1016/j.jmii.2017.01.006] [PMID]
  45. Almeida AA, Crispim Bdo A, Grisolia AB, Svidzinski TI, Ortolani LG, Oliveira KM. Genotype, antifungal susceptibility, and biofilm formation of Trichosporon asahii isolated from the urine of hospitalized patients. Rev Argent Microbiol. 2016;48(1):62-6. [DOI:10.1016/j.ram.2015.11.005] [PMID]
  46. Magalhães YC, Bomfim MR, Melônio LC, Ribeiro PC, Cosme LM, Rhoden CR, et al. Clinical significance of the isolation of Candida species from hospitalized patients. Braz J Microbiol. 2015;46(1): 117-23. [DOI:10.1590/S1517-838246120120296] [PMID] [PMCID]
  47. Farrag HA, A-Karam El-Din A, Mohamed El-Sayed ZG, Abdel-Latifissa S, Kamal MM. Microbial colonization of irradiated pathogenic yeast to catheter surfaces: Relationship between adherence, cell surface hydrophobicity, biofilm formation and antifungal susceptibility. A scanning electron microscope analysis. Int J Radiat Biol. 2015;91(6):519-27. [DOI:10.3109/09553002.2015.1021959] [PMID]
  48. Sulaiman SP, Singh R, Mandal J. Fungal profile of funguria cases at a tertiary care hospital in southern India. Indian J Med Res. 2014;140(4):556-9. [PMID] [PMCID]
  49. Iturrieta-González IA, Padovan AC, Bizerra FC, Hahn RC, Colombo AL. Multiple species of Trichosporon produce biofilms highly resistant to triazoles and amphotericin B. PLoS One. 2014;9(10):e109553. [DOI:10.1371/journal.pone.0109553] [PMID] [PMCID]
  50. Oh WS, Hur JA, Kim ES, Park KH, Choi HK, Moon C, et al. Factors associated with specific uropathogens in catheter-associated urinary tract infection: developing a clinical prediction model. J Int Med Res. 2014;42(6):1335-47. [DOI:10.1177/0300060514543035] [PMID]
  51. Taverna CG, Córdoba S, Murisengo OA, Vivot W, Davel G, Bosco-Borgeat ME. Molecular identification, genotyping, and antifungal susceptibility testing of clinically relevant Trichosporon species from Argentina. Med Mycol. 2014;52(4):356-66. [DOI:10.1093/mmy/myt029] [PMID]
  52. Treviño M, García-Riestra C, Areses P, García X, Navarro D, Suárez FJ, et al. Emerging Trichosporon asahii in elderly patients: epidemiological and molecular analysis by the DiversiLab system. Eur J Clin Microbiol Infect Dis. 2014;33(9):1497-503. [DOI:10.1007/s10096-014-2099-6] [PMID]
  53. Rathor N, Khillan V, Sarin SK. Nosocomial candiduria in chronic liver disease patients at a hepatobilliary center. Indian J Crit Care Med. 2014;18(4):234-7. [DOI:10.4103/0972-5229.130575] [PMID] [PMCID]
  54. Sun W, Su J, Xu S, Yan D. Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing. J Med Microbiol. 2012;61(12):1750-7. [DOI:10.1099/jmm.0.049817-0] [PMID]
  55. Tsai MS, Yang YL, Wang AH, Wang LS, Lu DC, Liou CH, et al. Susceptibilities to amphotericin B, fluconazole and voriconazole of Trichosporon clinical isolates. Mycopathologia. 2012;174(2):121-30. DOI: 10.1007/s11046-012-9525-z. [DOI:10.1007/s11046-012-9525-z] [PMID]
  56. Kim J, Kim DS, Lee YS, Choi NG. Fungal urinary tract infection in burn patients with long-term foley catheterization. Korean J Urol. 2011;52(9):626-31. [DOI:10.4111/kju.2011.52.9.626] [PMID] [PMCID]
  57. Marra AR, Sampaio Camargo TZ, Gonçalves P, Sogayar AM, Moura DF Jr, Guastelli LR, et al. Preventing catheter-associated urinary tract infection in the zero-tolerance era. Am J Infect Control. 2011; 39(10):817-22. [DOI:10.1016/j.ajic.2011.01.013] [PMID]
  58. Karahan ZC, Koyuncu E, Dolapci I, Akan ÖA, Can F, Tekeli A. Genotyping of Trichosporon asahii strains isolated from urinary tract infections in a Turkish university hospital. Turkish J Med Sci. 2010; 40(3):485-93. [DOI:10.3906/sag-0904-8]
  59. Netsvyetayeva I, Swoboda-Kopeć E, Paczek L, Fiedor P, Sikora M, Jaworska-Zaremba M, et al. Trichosporon asahii as a prospective pathogen in solid organ transplant recipients. Mycoses. 2009;52(3):263-5. [DOI:10.1111/j.1439-0507.2008.01590.x] [PMID]
  60. Taj-Aldeen SJ, Al-Ansari N, El Shafei S, Meis JF, Curfs-Breuker I, Theelen B, et al. Molecular identification and susceptibility of Trichosporon species isolated from clinical specimens in Qatar: isolation of Trichosporon dohaense Taj-Aldeen, Meis & Boekhout sp. nov. J Clin Microbiol. 2009; 47(6): 1791-9. [DOI:10.1128/JCM.02222-08] [PMID] [PMCID]
  61. Nawrot U, Nowicka J, Kuliczkowski K. Evaluation of Mycobiota in Patients with Hematological Malignancies in One− Day Examination. Adv Clin Exp Med. 2009;18(1):55-62.
  62. Eryüksel E, Ergönül Ö, Olgun Ș, Odabașı Z, Korten V, Çelİkel T. Risk factors for mortality in fungal infections. Turkiye Klin J Med Sci. 2009;29(1):99-103.
  63. de Oliveira Silva RB, Fusco-Almeida AM, Matsumoto MT, Baeza LC, Benaducci T, Mendes-Giannini MJ. Genetic diversity and antifungal susceptibility testing of Trichosporon asahii isolated of Intensive Care Units patients. Braz J Microbiol. 2008;39(3):585-92. [DOI:10.1590/S1517-83822008000300033] [PMID] [PMCID]
  64. Araujo Ribeiro M, Alastruey-Izquierdo A, Gomez-Lopez A, Rodriguez-Tudela JL, Cuenca-Estrella M. Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital. Rev Iberoam Micol. 2008;25(4):221-5. [DOI:10.1016/S1130-1406(08)70053-6] [PMID]
  65. Paul N, Mathai E, Abraham OC, Michael JS, Mathai D. Factors associated with candiduria and related mortality. J Infect. 2007;55(5):450-5. [DOI:10.1016/j.jinf.2007.06.010] [PMID]
  66. da Silva EH, Ruiz Lda S, Matsumoto FE, Auler ME, Giudice MC, Moreira D, et al. Candiduria in a public hospital of São Paulo (1999-2004): characteristics of the yeast isolates. Rev Inst Med Trop Sao Paulo. 2007;49(6):349-53. [DOI:10.1590/S0036-46652007000600003] [PMID]
  67. Ahmad S, Al-Mahmeed M, Khan ZU. Characterization of Trichosporon species isolated from clinical specimens in Kuwait. J Med Microbiol. 2005;54(7):639-46. [DOI:10.1099/jmm.0.45972-0] [PMID]
  68. Rodriguez-Tudela JL, Diaz-Guerra TM, Mellado E, Cano V, Tapia C, Perkins A, et al. Susceptibility patterns and molecular identification of Trichosporon species. Antimicrob Agents Chemother. 2005; 49(10):4026-34. [PMID] [PMCID] [DOI:10.1128/AAC.49.10.4026-4034.2005]
  69. Lussier N, Laverdière M, Delorme J, Weiss K, Dandavino R. Trichosporon beigelii funguria in renal transplant recipients. Clin Infect Dis. 2000;31(5):1299-301. [DOI:10.1086/317463] [PMID]
  70. Matsumoto T, Haraoka M, Kubo S, Takahashi K, Tanaka M, Ogata N, et al. Beta-D-glucan concentrations detected by Toxicolor and Endospecy tests in the urine of patients with urinary fungal infections. Urol Res. 1993;21(2):117-20. [DOI:10.1007/BF01788829] [PMID]
  71. Rajendran C, Basu TK, Baby A, Kumari S, Verghese T. Incidence and significance of opportunistic fungi in leukemia patients in India. Mycopathologia. 1992;119(2):83-7. [DOI:10.1007/BF00443938] [PMID]
  72. Al-Hedaithy SS. The medically important yeasts present in clinical specimens. Ann Saudi Med. 1992;12(1):57-62. [DOI:10.5144/0256-4947.1992.57] [PMID]
  73. Stone J, Manasse R. Pseudoepidemic of urinary tract infections due to Trichosporon beigelii. Infect Control Hosp Epidemiol. 1989;10(7):312-5. [DOI:10.1086/646034] [PMID]
  74. Ahearn DG, Jannach JR, Roth FJ Jr. Speciation and densities of yeasts in human urine specimens. Sabouraudia. 1966;5(2):110-9. [DOI:10.1080/00362176785190201] [PMID]
  75. Tamayo Lomas L, Domínguez-Gil González M, Martín Luengo AI, Eiros Bouza JM, Piqueras Pérez JM. Infección nosocomial por Trichosporon asahii en un paciente quemado crítico [Nosocomial infection due to Trichosporon asahii in a critical burned patient]. Rev Iberoam Micol. 2015;32(4):257-60. Spanish. [DOI:10.1016/j.riam.2014.07.005] [PMID]
  76. Heslop OD, Nyi Nyi MP, Abbott SP, Rainford LE, Castle DM, Coard KC. Disseminated trichosporonosis in a burn patient: meningitis and cerebral abscess due to Trichosporon asahii. J Clin Microbiol. 2011;49(12):4405-8. [DOI:10.1128/JCM.05028-11] [PMID] [PMCID]
  77. Shah AV, McColley SA, Weil D, Zheng X. Trichosporon mycotoxinivorans infection in patients with cystic fibrosis. J Clin Microbiol. 2014; 52(6):2242-4. [DOI:10.1128/JCM.03309-13] [PMID] [PMCID]
  78. Chander J. Oxford Textbook of Medical Mycology. Oxford Textbook of Medical Mycology. 2018. New Delhi: Jaypee Publishers; 1-905.
  79. Kourti M, Roilides E. Invasive Trichosporonosis in Neonates and Pediatric Patients with Malignancies or Hematologic Disorders. Pathogens. 2022;11(2):242. [DOI:10.3390/pathogens11020242] [PMID] [PMCID]
  80. Guo LN, Xiao M, Kong F, Chen SC, Wang H, Sorrell TC, et al. Three-locus identification, genotyping, and antifungal susceptibilities of medically important Trichosporon species from China. J Clin Microbiol. 2011;49(11):3805-11. [DOI:10.1128/JCM.00937-11] [PMID] [PMCID]
  81. Xiao M, Guo LN, Kong F, Wang H, Sorrell TC, Li RY, et al. Practical identification of eight medically important Trichosporon species by reverse line blot hybridization (RLB) assay and rolling circle amplification (RCA). Med Mycol. 2013;51(3):300-8. [DOI:10.3109/13693786.2012.723223] [PMID] [PMCID]
  82. Parashar A, Rastogi V, Prakash H, Rudramurthy SM. P441 Molecular identification, genotyping, and antifungal susceptibility of Trichosporon species isolated from clinical samples of patients at various parts of the Indian subcontinent. Med Mycol. 2022;60(Suppl 1):myac072P441. [DOI:10.1093/mmy/myac072.P441] [PMCID]
  83. Walsh TJ, Melcher GP, Rinaldi MG, Lecciones J, McGough DA, Kelly P, et al. Trichosporon beigelii, an emerging pathogen resistant to amphotericin B. J Clin Microbiol. 1990;28(7):1616-22. [PMID] [PMCID] [DOI:10.1128/jcm.28.7.1616-1622.1990]
  84. Girmenia C, Pagano L, Martino B, D'Antonio D, Fanci R, Specchia G, et al. Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature. J Clin Microbiol. 2005;43(4):1818-28. [DOI:10.1128/JCM.43.4.1818-1828.2005] [PMID] [PMCID]
  85. Bassetti M, Bisio F, Di Biagio A, Pierri I, Balocco M, Soro O, et al. Trichosporon asahii infection treated with caspofungin combined with liposomal amphotericin B. J Antimicrob Chemother. 2004;54(2):575-7. [DOI:10.1093/jac/dkh337] [PMID]
  86. Cejudo MA, Gallego AG, Lacasa EC, Aller AI, Romero A, García JP, et al. Evaluation of the VITEK 2 system to test the susceptibility of Candida spp., Trichosporon asahii and Cryptococcus neoformans to amphotericin B, flucytosine, fluconazole and voriconazole: a comparison with the M27-A3 reference method. Med Mycol. 2010;48(5):710-9. [DOI:10.3109/13693780903473343] [PMID]
  87. Lemes RM, Lyon JP, Moreira LM, de Resende MA. Antifungal susceptibility profile of Trichosporon isolates: correlation between CLSI and etest methodologies. Braz J Microbiol. 2010;41(2):310-5. [DOI:10.1590/S1517-83822010000200008] [PMID] [PMCID]
Iranian Journal of Pathology
Volume 20, Issue 4
Summer 2025
Pages 367-379

  • Receive Date 31 January 2025
  • Revise Date 03 February 2025
  • Accept Date 09 July 2025

Home

Guide for Authors

Submit Manuscript

Contact Us